We are proposing to establish a Vermont Center on Tobacco Regulatory Science (VCTRS) at the University of Vermont (UVM) in collaboration with colleagues from Brown University, Johns Hopkins University, University of Minnesota, and University of Pittsburgh. The VCTRS will focus on researching the effects of new tobacco products in vulnerable populations, with special emphasis on reducing the addiction potential of cigarettes and other tobacco products by reducing their nicotine content and examining the impact of these products on biomarkers of exposure and health outcomes. Each of these foci was selected to address crosscutting and specific priorities of the FDA outlined in RFA-DA-13-003. We will establish an administrative core at UVM that will provide the senior scientific and administrative leadership and support that is essential to a vibrant and successful multidisciplinary center of research excellence. We are proposing three primary research projects that will be complemented by a program of developmental research. In addition to this research mission, the VCTRS will also establish a predoctoral and postdoctoral training program in tobacco regulatory science that will be primarily located at UVM but will also include training at Brown University and Johns Hopkins University. The research and training missions will be led by experts in addictions research in collaboration with accomplished experts in biomarkers and health outcomes from the disciplines of biochemistry, family practice, internal medicine, and obstetrics and gynecology. There is strong institutional support for establishing the VCTRS at UVM that runs from the departmental level through the highest administrative offices and extending out into key Vermont state offices that are involved in establishing and implementing the state's tobacco control policies (see Letters of Support). Below we expound on each of these key aspects of establishing the VCTRS. One other point that we want to mention now, and expound upon below, is our plan to study the potential of very low nicotine content (VLNC) cigarettes for reducing the abuse liability of cigarettes. This should not be confused with earlier failed efforts to develop """"""""light"""""""" cigarettes for the same purpose. VLNC cigarettes actually have lower nicotine content as opposed to the earlier ineffective strategy of keeping nicotine content the same and attempting to lower nicotine yield through ventilation, which smokers often circumvented with compensatory smoking. These are different strategies and, while still limited, the evidence on VLNC cigarettes lowering the abuse liability of cigarettes is quite promising.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Specialized Center (P50)
Project #
5P50DA036114-02
Application #
8737849
Study Section
Special Emphasis Panel (ZRG1)
Project Start
Project End
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
2
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of Vermont & St Agric College
Department
Type
DUNS #
City
Burlington
State
VT
Country
United States
Zip Code
05405
Veal, Christopher Thomas; Hart, Vicki; Lakoski, Susan G et al. (2017) Health-related behaviors and mortality outcomes in women diagnosed with ductal carcinoma in situ. J Cancer Surviv 11:320-328
Arger, Christopher A; Heil, Sarah H; Sigmon, Stacey C et al. (2017) Preliminary validity of the modified Cigarette Evaluation Questionnaire in predicting the reinforcing effects of cigarettes that vary in nicotine content. Exp Clin Psychopharmacol 25:473-478
Zvorsky, Ivori; Skelly, Joan M; Higgins, Stephen T (2017) Effects of Financial Incentives for Smoking Cessation on Mood and Anxiety Symptoms Among Pregnant and Newly Postpartum Women. Nicotine Tob Res :
Albaugh, Matthew D; Orr, Catherine; Chaarani, Bader et al. (2017) Inattention and Reaction Time Variability Are Linked to Ventromedial Prefrontal Volume in Adolescents. Biol Psychiatry 82:660-668
Phillips, Julie K; Skelly, Joan M; King, Sarah E et al. (2017) Associations of maternal obesity and smoking status with perinatal outcomes. J Matern Fetal Neonatal Med :1-7
Kurti, Allison N; Redner, Ryan; Lopez, Alexa A et al. (2017) Tobacco and nicotine delivery product use in a national sample of pregnant women. Prev Med 104:50-56
Roberts, Megan E; Doogan, Nathan J; Stanton, Cassandra A et al. (2017) Rural Versus Urban Use of Traditional and Emerging Tobacco Products in the United States, 2013-2014. Am J Public Health 107:1554-1559
Villanti, Andrea C; Collins, Lauren K; Niaura, Raymond S et al. (2017) Menthol cigarettes and the public health standard: a systematic review. BMC Public Health 17:983
Miller, Mollie E; Tidey, Jennifer W; Rohsenow, Damaris J et al. (2017) Electronic Cigarette Expectancies in Smokers with Psychological Distress. Tob Regul Sci 3:108-114
Higgins, Stephen T; Reed, Derek D; Redner, Ryan et al. (2017) Simulating demand for cigarettes among pregnant women: A Low-Risk method for studying vulnerable populations. J Exp Anal Behav 107:176-190

Showing the most recent 10 out of 51 publications